The presence of the VANGL2–p62/SQSTM1 complex in breast cancer PDX protein extracts was confirmed by VANGL2 immunoprecipitation followed by western blot analysis (Supplementary Fig. 7). This evidence concerns the gene VANGL2 and breast carcinoma.